Attached files
| file | filename |
|---|---|
| EXCEL - IDEA: XBRL DOCUMENT - HALOZYME THERAPEUTICS, INC. | Financial_Report.xls |
| EX-31.2 - CERTIFICATION OF CHIEF FINANCIAL OFFICER - HALOZYME THERAPEUTICS, INC. | d295326dex312.htm |
| EX-31.1 - CERTIFICATION OF CHIEF EXECUTIVE OFFICER - HALOZYME THERAPEUTICS, INC. | d295326dex311.htm |
| 10-K - FORM 10-K - HALOZYME THERAPEUTICS, INC. | d295326d10k.htm |
| EX-32 - CERTIFICATION OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER - HALOZYME THERAPEUTICS, INC. | d295326dex32.htm |
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the Registration Statements on Form S-3 (Nos. 333-120448 and 333-179444) and Form S-8 (Nos. 333-119969, 333-133829, 333-152914 and 333-174013) of Halozyme Therapeutics, Inc. and in the related Prospectuses of our reports dated March 9, 2012, with respect to the consolidated financial statements of Halozyme Therapeutics, Inc., and the effectiveness of internal control over financial reporting of Halozyme Therapeutics, Inc., included in this Annual Report (Form 10-K) for the year ended December 31, 2011.
/s/ Ernst & Young LLP
San Diego, California
March 9, 2012